These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1362733)

  • 1. Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone.
    Gil-Ad I; Klinger B; Pertzelan A; Erster B; Silbergeld A; Talpaz H; Laron Z
    J Endocrinol Invest; 1992 Nov; 15(10):735-9. PubMed ID: 1362733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
    Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulated growth hormone (GH) secretion in children with delays in pubertal development before and after the onset of puberty: relationship with peripheral plasma GH-releasing hormone and somatostatin levels.
    Saggese G; Cesaretti G; Giannessi N; Bracaloni C; Cinquanta L; Cioni C
    J Clin Endocrinol Metab; 1992 Feb; 74(2):272-8. PubMed ID: 1346143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of growth hormone-releasing hormone and somatostatin in response to a mixed meal and during sleep in children.
    Rosskamp R; Becker M; Haverkamp F; Thomas B; Brühl S; Klumpp J; Liappis N
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):549-54. PubMed ID: 2892332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of the effects of growth hormone release inhibiting factor enhances plasma growth hormone response to GHRH.
    Shi YF; Fang XD
    Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(1):13-8. PubMed ID: 2565570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children.
    Donnadieu M; Evain-Brion D; Tonon MC; Vaudry H; Job JC
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1132-4. PubMed ID: 3923020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin-induced hypoglycemia on circulating levels of plasma growth hormone-releasing hormone and somatostatin in children.
    Rosskamp R; Becker M; Tegeler A; Klumpp J
    Horm Res; 1987; 27(3):121-5. PubMed ID: 2891599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone releasing hormone in the assessment and long-term treatment of growth hormone deficiency.
    Ross RJ; Grossman A; Preece MA; Savage MO; Besser GM
    Acta Paediatr Scand Suppl; 1987; 331():42-7. PubMed ID: 3111168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency.
    Hanew K; Goh M; Sato S; Shimizu Y; Sasaki A; Aida M; Yoshinaga K
    J Clin Endocrinol Metab; 1988 Apr; 66(4):715-21. PubMed ID: 3126213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of growth hormone (GH) gene expression and secretion during pregnancy and lactation in the rat: role of insulin-like growth factor-I, somatostatin, and GH-releasing hormone.
    Escalada J; Sánchez-Franco F; Velasco B; Cacicedo L
    Endocrinology; 1997 Aug; 138(8):3435-43. PubMed ID: 9231798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral clonidine, insulin-induced hypoglycemia and exercise on plasma GHRH levels in short-stature children.
    Gil-Ad I; Leibowitch N; Josefsberg Z; Wasserman M; Laron Z
    Acta Endocrinol (Copenh); 1990 Jan; 122(1):89-95. PubMed ID: 2106191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a).
    Laron Z; Wang XL; Klinger B; Silbergeld A; Wilcken DE
    Eur J Endocrinol; 1997 Apr; 136(4):377-81. PubMed ID: 9150696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
    Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
    Gianotti L; Arvat E; Valetto MR; Ramunni J; Di Vito L; Maccagno B; Camanni F; Ghigo E
    Biol Psychiatry; 1998 Feb; 43(3):181-7. PubMed ID: 9494699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
    Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
    Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion.
    Moller DE; Moses AC; Jones K; Thorner MO; Vance ML
    J Clin Endocrinol Metab; 1989 Feb; 68(2):499-504. PubMed ID: 2493033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.